Nexalin Historical Financial Ratios

NXL Stock

USD 2.92 0.04 1.39%

Nexalin Technology is lately reporting on over 86 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 14.95 will help investors to properly organize and evaluate Nexalin Technology financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.

About Nexalin Financial Ratios Analysis

Nexalin TechnologyFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Nexalin Technology investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Nexalin financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Nexalin Technology history.

Nexalin Technology Financial Ratios Chart

At this time, Nexalin Technology's Payables Turnover is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 49.33 this year, although the value of Days Sales Outstanding will most likely fall to 14.95.

Price To Sales Ratio Days Sales Outstanding Average Payables Ev To Sales

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Nexalin Technology stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Nexalin Technology sales, a figure that is much harder to manipulate than other Nexalin Technology multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Nexalin Technology's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Nexalin Technology current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.At this time, Nexalin Technology's Payables Turnover is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 49.33 this year, although the value of Days Sales Outstanding will most likely fall to 14.95.

	2022	2023	2024	2025 (projected)
Payables Turnover	0.55	0.16	0.19	0.32
Days Of Inventory On Hand	155.13	2.2K	2.0K	2.1K

Payables Turnover Days Of Inventory On Hand

Nexalin Technology fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		-0.87	0.09	-0.95	0.75	0.79	-0.26	-0.62	-0.87	1.0	0.79	0.94	0.58	-0.81	-0.62	0.25	-0.62	-0.84	-0.83	0.59	0.64	-0.83	0.22	-0.9	0.88	-0.83
Ptb Ratio	-0.87		0.37	0.93	-0.89	-0.94	0.41	0.91	1.0	-0.9	-0.94	-0.89	-0.87	0.59	0.84	-0.62	0.91	0.82	1.0	-0.85	-0.92	1.0	0.25	0.88	-0.99	1.0
Days Sales Outstanding	0.09	0.37		0.1	-0.46	-0.46	0.15	0.62	0.37	0.02	-0.46	-0.1	-0.6	-0.41	0.61	-0.75	0.62	0.04	0.44	-0.65	-0.62	0.44	0.74	0.11	-0.35	0.45
Book Value Per Share	-0.95	0.93	0.1		-0.77	-0.83	0.46	0.8	0.93	-0.96	-0.83	-0.9	-0.66	0.72	0.66	-0.32	0.8	0.93	0.91	-0.65	-0.8	0.91	-0.04	0.95	-0.9	0.91
Free Cash Flow Yield	0.75	-0.89	-0.46	-0.77		0.99	0.0	-0.76	-0.89	0.8	0.99	0.91	0.73	-0.3	-0.97	0.55	-0.76	-0.52	-0.9	0.96	0.81	-0.9	-0.14	-0.62	0.93	-0.9
Operating Cash Flow Per Share	0.79	-0.94	-0.46	-0.83	0.99		-0.12	-0.82	-0.94	0.84	1.0	0.92	0.79	-0.38	-0.96	0.58	-0.82	-0.61	-0.95	0.95	0.87	-0.95	-0.19	-0.7	0.96	-0.95
Average Payables	-0.26	0.41	0.15	0.46	0.0	-0.12		0.62	0.41	-0.25	-0.11	-0.05	-0.44	0.41	-0.02	-0.28	0.61	0.7	0.41	-0.03	-0.55	0.41	0.46	0.58	-0.26	0.41
Capex To Depreciation	-0.62	0.91	0.62	0.8	-0.76	-0.82	0.62		0.91	-0.66	-0.82	-0.65	-0.88	0.33	0.76	-0.69	1.0	0.75	0.93	-0.8	-0.99	0.93	0.53	0.77	-0.84	0.93
Pb Ratio	-0.87	1.0	0.37	0.93	-0.89	-0.94	0.41	0.91		-0.9	-0.94	-0.89	-0.87	0.59	0.84	-0.62	0.91	0.82	1.0	-0.85	-0.92	1.0	0.25	0.88	-0.99	1.0
Ev To Sales	1.0	-0.9	0.02	-0.96	0.8	0.84	-0.25	-0.66	-0.9		0.83	0.96	0.62	-0.78	-0.68	0.31	-0.66	-0.83	-0.87	0.65	0.69	-0.87	0.17	-0.89	0.92	-0.86
Free Cash Flow Per Share	0.79	-0.94	-0.46	-0.83	0.99	1.0	-0.11	-0.82	-0.94	0.83		0.92	0.79	-0.37	-0.96	0.58	-0.82	-0.6	-0.94	0.96	0.87	-0.94	-0.19	-0.69	0.96	-0.94
Roic	0.94	-0.89	-0.1	-0.9	0.91	0.92	-0.05	-0.65	-0.89	0.96	0.92		0.61	-0.6	-0.82	0.33	-0.65	-0.69	-0.87	0.78	0.69	-0.87	0.16	-0.78	0.93	-0.86
Inventory Turnover	0.58	-0.87	-0.6	-0.66	0.73	0.79	-0.44	-0.88	-0.87	0.62	0.79	0.61		-0.42	-0.78	0.92	-0.88	-0.6	-0.89	0.82	0.88	-0.89	-0.64	-0.67	0.86	-0.89
Net Income Per Share	-0.81	0.59	-0.41	0.72	-0.3	-0.38	0.41	0.33	0.59	-0.78	-0.37	-0.6	-0.42		0.15	-0.15	0.33	0.79	0.53	-0.15	-0.33	0.53	-0.22	0.79	-0.58	0.53
Days Of Inventory On Hand	-0.62	0.84	0.61	0.66	-0.97	-0.96	-0.02	0.76	0.84	-0.68	-0.96	-0.82	-0.78	0.15		-0.67	0.77	0.4	0.86	-0.99	-0.81	0.86	0.3	0.52	-0.89	0.87
Payables Turnover	0.25	-0.62	-0.75	-0.32	0.55	0.58	-0.28	-0.69	-0.62	0.31	0.58	0.33	0.92	-0.15	-0.67		-0.69	-0.28	-0.66	0.72	0.69	-0.66	-0.79	-0.38	0.63	-0.66
Capex To Revenue	-0.62	0.91	0.62	0.8	-0.76	-0.82	0.61	1.0	0.91	-0.66	-0.82	-0.65	-0.88	0.33	0.77	-0.69		0.75	0.93	-0.8	-0.99	0.93	0.53	0.77	-0.84	0.93
Cash Per Share	-0.84	0.82	0.04	0.93	-0.52	-0.61	0.7	0.75	0.82	-0.83	-0.6	-0.69	-0.6	0.79	0.4	-0.28	0.75		0.79	-0.41	-0.73	0.79	0.02	0.98	-0.74	0.79
Pocfratio	-0.83	1.0	0.44	0.91	-0.9	-0.95	0.41	0.93	1.0	-0.87	-0.94	-0.87	-0.89	0.53	0.86	-0.66	0.93	0.79		-0.87	-0.95	1.0	0.3	0.85	-0.98	1.0
Interest Coverage	0.59	-0.85	-0.65	-0.65	0.96	0.95	-0.03	-0.8	-0.85	0.65	0.96	0.78	0.82	-0.15	-0.99	0.72	-0.8	-0.41	-0.87		0.85	-0.87	-0.39	-0.51	0.88	-0.88
Capex To Operating Cash Flow	0.64	-0.92	-0.62	-0.8	0.81	0.87	-0.55	-0.99	-0.92	0.69	0.87	0.69	0.88	-0.33	-0.81	0.69	-0.99	-0.73	-0.95	0.85		-0.95	-0.51	-0.75	0.87	-0.95
Pfcf Ratio	-0.83	1.0	0.44	0.91	-0.9	-0.95	0.41	0.93	1.0	-0.87	-0.94	-0.87	-0.89	0.53	0.86	-0.66	0.93	0.79	1.0	-0.87	-0.95		0.3	0.85	-0.98	1.0
Days Payables Outstanding	0.22	0.25	0.74	-0.04	-0.14	-0.19	0.46	0.53	0.25	0.17	-0.19	0.16	-0.64	-0.22	0.3	-0.79	0.53	0.02	0.3	-0.39	-0.51	0.3		0.01	-0.2	0.32
Income Quality	-0.9	0.88	0.11	0.95	-0.62	-0.7	0.58	0.77	0.88	-0.89	-0.69	-0.78	-0.67	0.79	0.52	-0.38	0.77	0.98	0.85	-0.51	-0.75	0.85	0.01		-0.82	0.85
Roe	0.88	-0.99	-0.35	-0.9	0.93	0.96	-0.26	-0.84	-0.99	0.92	0.96	0.93	0.86	-0.58	-0.89	0.63	-0.84	-0.74	-0.98	0.88	0.87	-0.98	-0.2	-0.82		-0.98
Ev To Operating Cash Flow	-0.83	1.0	0.45	0.91	-0.9	-0.95	0.41	0.93	1.0	-0.86	-0.94	-0.86	-0.89	0.53	0.87	-0.66	0.93	0.79	1.0	-0.88	-0.95	1.0	0.32	0.85	-0.98

Click cells to compare fundamentals

Nexalin Technology Account Relationship Matchups

Nexalin Technology fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	67.43	113.7	4.13	26.89	30.92	29.38
Ptb Ratio	(10.3)	(9.74)	1.0	0.93	0.84	0.88
Days Sales Outstanding	9.92	41.3	1.35	30.88	27.79	14.95
Book Value Per Share	(0.22)	(0.23)	0.75	0.44	0.39	0.41
Free Cash Flow Yield	(0.0528)	(0.0657)	(0.41)	(1.32)	(1.52)	(1.45)
Operating Cash Flow Per Share	(0.12)	(0.15)	(0.3)	(0.52)	(0.6)	(0.57)
Stock Based Compensation To Revenue	8.07	31.08	0.2	21.79	19.61	10.22
Pb Ratio	(10.3)	(9.74)	1.0	0.93	0.84	0.88
Ev To Sales	70.1	115.0	4.58	21.69	24.95	23.7
Free Cash Flow Per Share	(0.12)	(0.15)	(0.3)	(0.54)	(0.62)	(0.59)
Roic	3.86	7.33	(0.33)	(1.77)	(2.04)	(1.94)
Inventory Turnover	1.28	0.68	2.35	0.16	0.19	0.18
Net Income Per Share	(0.48)	(0.85)	(0.26)	(0.63)	(0.57)	(0.6)
Days Of Inventory On Hand	284.77	534.68	155.13	2.2K	2.0K	2.1K
Payables Turnover	0.063	0.0254	0.55	0.16	0.19	0.32
Sales General And Administrative To Revenue	14.29	42.63	2.11	52.2	46.98	49.33
Cash Per Share	0.0108	0.0909	0.96	0.4	0.36	0.23
Pocfratio	(18.97)	(15.21)	(2.46)	(0.78)	(0.7)	(0.73)
Interest Coverage	(41.41)	(73.11)	(30.87)	(146.68)	(168.68)	(160.25)
Pfcf Ratio	(18.96)	(15.21)	(2.46)	(0.75)	(0.68)	(0.71)
Days Payables Outstanding	5.8K	14.4K	661.61	2.3K	2.6K	5.2K
Income Quality	0.25	0.18	1.31	0.83	0.74	0.43
Roe	2.19	3.66	(0.35)	(1.45)	(1.67)	(1.58)
Ev To Operating Cash Flow	(19.72)	(15.39)	(2.73)	(0.63)	(0.56)	(0.59)
Pe Ratio	(4.7)	(2.66)	(2.83)	(0.64)	(0.58)	(0.61)
Return On Tangible Assets	(29.4)	(8.17)	(0.26)	(1.32)	(1.19)	(1.25)
Ev To Free Cash Flow	(19.7)	(15.39)	(2.73)	(0.61)	(0.55)	(0.58)
Earnings Yield	(0.21)	(0.38)	(0.35)	(1.56)	(1.8)	(1.71)
Net Debt To E B I T D A	(0.19)	(0.0314)	(0.32)	0.1	0.091	0.0956
Current Ratio	0.0746	0.32	3.81	8.07	7.26	7.62
Tangible Book Value Per Share	(0.22)	(0.23)	0.75	0.42	0.38	0.4
Receivables Turnover	36.81	8.84	271.05	11.82	10.64	10.11
Graham Number	1.53	2.1	2.11	2.49	2.24	1.57
Shareholders Equity Per Share	(0.22)	(0.23)	0.75	0.44	0.39	0.41
Debt To Equity	(0.46)	(0.51)	0.14	0.001392	0.001253	0.001315
Graham Net Net	(0.22)	(0.24)	0.7	0.35	0.32	0.34
Revenue Per Share	0.0334	0.0198	0.18	0.0151	0.0135	0.0129

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:

How To Invest In Nexalin

Details

Is Nexalin Stock a good investment?

Details

What is Nexalin Technology's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.

You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.65)

Revenue Per Share

0.02

Quarterly Revenue Growth

(0.24)

Return On Assets

(1.19)

Return On Equity

(2.02)

The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Nexalin Historical Financial Ratios

About Nexalin Financial Ratios Analysis

Nexalin Technology Financial Ratios Chart

Price To Sales Ratio

Average Payables

Ev To Sales

Nexalin Technology fundamentals Correlations

Nexalin Technology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nexalin Technology fundamentals Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Pocfratio	+ 1.0	Ptb Ratio
Pfcf Ratio	+ 1.0	Ptb Ratio
Ev To Operating Cash Flow	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share

Capex To Operating Cash Flow	- 0.99	Capex To Revenue
Interest Coverage	- 0.99	Days Of Inventory On Hand
Roe	- 0.99	Pb Ratio
Capex To Operating Cash Flow	- 0.99	Capex To Depreciation
Roe	- 0.99	Ptb Ratio
Ev To Operating Cash Flow	- 0.98	Roe